Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND RAF1, Raf-1, 5894, P04049, ENSG00000132155, c-Raf, CRAF AND Prognosis
17 results:

  • 1. The EIF3H-HAX1 axis increases RAF-MEK-ERK signaling activity to promote colorectal cancer progression.
    Jin H; Huang X; Pan Q; Ma N; Xie X; Wei Y; Yu F; Wen W; Zhang B; Zhang P; Chen X; Wang J; Liu RY; Lin J; Meng X; Lee MH
    Nat Commun; 2024 Mar; 15(1):2551. PubMed ID: 38514606
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Site specific genetic differences in colorectal cancer via Next-Generation-Sequencing using a multigene panel.
    Rencuzogullari A; Bisgin A; Erdogan KE; Gumus S; Yalav O; Boga I; Sonmezler O; Eray IC
    Ann Ital Chir; 2023; 94():605-611. PubMed ID: 38131395
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. KRAS Pathways: A Potential Gateway for cancer Therapeutics and Diagnostics.
    Tripathi PK; Mittal KR; Jain N; Sharma N; Jain CK
    Recent Pat Anticancer Drug Discov; 2024; 19(3):268-279. PubMed ID: 37038676
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. STOML2 interacts with PHB through activating MAPK signaling pathway to promote colorectal cancer proliferation.
    Ma W; Chen Y; Xiong W; Li W; Xu Z; Wang Y; Wei Z; Mou T; Wu Z; Cheng M; Zou Y; Zhu Y; Zhou W; Liu F; Geng Y
    J Exp Clin Cancer Res; 2021 Nov; 40(1):359. PubMed ID: 34781982
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. 4-Acetyl-Antroquinonol B Improves the Sensitization of Cetuximab on Both Kras Mutant and Wild Type colorectal cancer by Modulating the Expression of Ras/Raf/miR-193a-3p Signaling Axis.
    Chu YC; Tsai TY; Yadav VK; Deng L; Huang CC; Tzeng YM; Yeh CT; Chen MY
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299137
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Characterization of a Novel Entity of G3 (High-grade Well-differentiated) colorectal Neuroendocrine Tumors (NET) in the SEER Database.
    Punekar SR; Kaakour D; Masri-Lavine L; Hajdu C; Newman E; Becker DJ
    Am J Clin Oncol; 2020 Dec; 43(12):846-849. PubMed ID: 32910023
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. PDCD6 cooperates with c-raf to facilitate colorectal cancer progression via Raf/MEK/ERK activation.
    Wang X; Wu F; Wang H; Duan X; Huang R; Tuersuntuoheti A; Su L; Yan S; Zhao Y; Lu Y; Li K; Yao J; Luo Z; Guo L; Liu J; Chen X; Lu Y; Hu H; Li X; Bao M; Bi X; Du B; Miao S; Cai J; Wang L; Zhou H; Ying J; Song W; Zhao H
    J Exp Clin Cancer Res; 2020 Aug; 39(1):147. PubMed ID: 32746883
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1.
    Zhang Y; Huang W; Yuan Y; Li J; Wu J; Yu J; He Y; Wei Z; Zhang C
    J Exp Clin Cancer Res; 2020 Jul; 39(1):141. PubMed ID: 32698890
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Identification of gene expression models for laryngeal squamous cell carcinoma using co-expression network analysis.
    Yang CW; Wang SF; Yang XL; Wang L; Niu L; Liu JX
    Medicine (Baltimore); 2018 Feb; 97(7):e9738. PubMed ID: 29443735
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Molecular profiling of metastatic colorectal tumors using next-generation sequencing: a single-institution experience.
    Gong J; Cho M; Sy M; Salgia R; Fakih M
    Oncotarget; 2017 Jun; 8(26):42198-42213. PubMed ID: 28178681
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Human Blood Autoantibodies in the Detection of colorectal cancer.
    Negm OH; Hamed MR; Schoen RE; Whelan RL; Steele RJ; Scholefield J; Dilnot EM; Shantha Kumara HM; Robertson JF; Sewell HF
    PLoS One; 2016; 11(7):e0156971. PubMed ID: 27383396
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis.
    Cremolini C; Di Bartolomeo M; Amatu A; Antoniotti C; Moretto R; Berenato R; Perrone F; Tamborini E; Aprile G; Lonardi S; Sartore-Bianchi A; Fontanini G; Milione M; Lauricella C; Siena S; Falcone A; de Braud F; Loupakis F; Pietrantonio F
    Ann Oncol; 2015 Oct; 26(10):2092-7. PubMed ID: 26153495
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. MicroRNA-7 expression in colorectal cancer is associated with poor prognosis and regulates cetuximab sensitivity via EGFR regulation.
    Suto T; Yokobori T; Yajima R; Morita H; Fujii T; Yamaguchi S; Altan B; Tsutsumi S; Asao T; Kuwano H
    Carcinogenesis; 2015 Mar; 36(3):338-45. PubMed ID: 25503932
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Reduced raf-1 kinase inhibitor protein expression predicts less favorable outcomes in patients with hepatic colorectal metastasis.
    Kim HS; Park SJ; Lee KY; Park YK; Kim YW
    Oncol Rep; 2012 Jul; 28(1):161-71. PubMed ID: 22562283
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3β.
    Al-Mulla F; Bitar MS; Al-Maghrebi M; Behbehani AI; Al-Ali W; Rath O; Doyle B; Tan KY; Pitt A; Kolch W
    Cancer Res; 2011 Feb; 71(4):1334-43. PubMed ID: 21303975
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. RHAMM, p21 combined phenotype identifies microsatellite instability-high colorectal cancers with a highly adverse prognosis.
    Zlobec I; Baker K; Terracciano LM; Lugli A
    Clin Cancer Res; 2008 Jun; 14(12):3798-806. PubMed ID: 18559599
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Common patterns of genetic evolution in human solid tumors.
    Shackney SE; Shankey TV
    Cytometry; 1997 Sep; 29(1):1-27. PubMed ID: 9298807
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.